Skip to main content
. 2013 Nov 9;12:170. doi: 10.1186/1476-511X-12-170

Table 4.

Predictors of LDL-C goal attainment

  Initial model Final model
 
OR (95% CIs)
P-value
OR (95% CIs)
P-value
Male gender
1.66 (0.88-3.13)
0.1
1.88 (1.03-3.44)
0.04
Age
1.02 (0.99-1.04)
0.3
 
 
DM
0.92 (0.49-1.76)
0.8
 
 
Smoking
0.62 (0.36-1.07)
0.09
0.57 (0.33-0.96)
0.04
CAD
1.34 (0.65-2.77)
0.4
 
 
PAD
1.53 (0.65-3.58)
0.3
 
 
Cerebrovascular disease
0.14 (0.02-1.004)
0.05
0.15 (0.02-1.14)
0.07
Baseline LDL-C (mg/dl)
0.99 (0.98-0.99)
<0.001
0.99 (0.98-0.99)
<0.001
Combined therapy with statin and ezetimibe
1.15 (0.56-2.34)
0.7
 
 
Very high potency LDL-C lowering regimen 1.94 (0.84-4.49) 0.1 2.21(1.15-4.24) 0.02

DM = diabetes mellitus, CAD = coronary artery disease, PAD = peripheral arterial disease, LDL-C = low density lipoprotein-cholesterol.